New Virus Filter Improves Biopharmaceutical Efficiency | |
Asahi Kasei Medical, a global leader in biopharmaceutical manufacturing solutions, has launched the Planova™ FG1, a next-generation virus removal filter, to meet the growing demands of the biopharmaceutical industry. Released in October 2024, the Planova™ FG1 is designed to significantly enhance the efficiency and safety of the biotherapeutic production process, offering groundbreaking improvements in viral safety. The Planova™ virus removal filters, a cornerstone of Asahi Kasei Medical’s bioprocess business, have been used in biopharmaceutical production since 1989. Over the years, the company has consistently improved its offerings, launching products such as Planova™ BioEX in 2009 and Planova™ S20N in 2022. The introduction of the Planova™ FG1 marks the next step in this evolutionary process, aimed at addressing the growing global demand for viral safety in biopharmaceuticals. For more details please visit our website - https://www.medhealthinsight.com/new-virus-filter-improves-biopharmaceutical-efficiency/ ![]() | |
Related Link: Click here to visit item owner's website (0 hit) | |
Target State: New York Target City : New York City Last Update : Jul 11, 2025 4:02 AM Number of Views: 4 | Item Owner : medhealthinsight Contact Email: (None) Contact Phone: (None) |
Friendly reminder: Click here to read some tips. |